LOCUS AK308068 1002 bp mRNA linear HTC 12-JAN-2008 DEFINITION Homo sapiens cDNA, FLJ98016. ACCESSION AK308068 VERSION AK308068.1 KEYWORDS HTC; HTC_FLI; oligo capping. SOURCE Homo sapiens (human) ORGANISM Homo sapiens Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo. REFERENCE 1 (bases 1 to 1002) AUTHORS Isogai,T. and Yamamoto,J. TITLE Direct Submission JOURNAL Submitted (11-JAN-2008) to the DDBJ/EMBL/GenBank databases. Contact:Takao Isogai Reverse Proteomics Research Institute; 1-9-11 Kaji-cho, Chiyoda-ku, Tokyo 101-0044, Japan E-mail :flj-cdna@nifty.com REFERENCE 2 AUTHORS Wakamatsu,A., Yamamoto,J., Kimura,K., Ishii,S., Watanabe,K., Sugiyama,A., Murakawa,K., Kaida,T., Tsuchiya,K., Fukuzumi,Y., Kumagai,A., Oishi,Y., Yamamoto,S., Ono,Y., Komori,Y., Yamazaki,M., Kisu,Y., Nishikawa,T., Sugano,S., Nomura,N. and Isogai,T. TITLE NEDO human cDNA sequencing project JOURNAL Unpublished (2008) COMMENT Human cDNA sequencing project focused on splicing variants of mRNA in NEDO functional analysis of protein and research application project supported by Ministry of Economy, Trade and Industry, Japan; cDNA selection for complete cds sequencing: Reverse Proteomics Research Institute (REPRORI), Hitachi, Ltd., Japan (Hitachi) and Japan Biological Informatics Consortium, Japan (JBIC); cDNA complete cds sequencing: JBIC; cDNA library construction: Helix Research Institute supported by Japan Key Technology Center, Japan (HRI); cDNA 5'- & 3'-end sequencing: Research Association for Biotechnology, Japan, Biotechnology Center, National Institute of Technology and Evaluation, Japan and HRI; cDNA mapping to human genome: Central Research Laboratory, Hitachi; evaluation and annotation: REPRORI. FEATURES Location/Qualifiers source 1..1002 /cell_line="NT2" /cell_type="teratocarcinoma" /clone="NT2RI2012396" /clone_lib="NT2RI2" /db_xref="H-InvDB:HIT000426934" /db_xref="taxon:9606" /mol_type="mRNA" /note="cloning vector: pME18SFL3" /note="mRNA from NT2 neuronal precursor cells treated 2-weeks mitotic inhibitor after 5-weeks retinoic acid (RA) induction." /note="majorly NT2 neuron" /organism="Homo sapiens" BASE COUNT 320 a 203 c 228 g 251 t ORIGIN 1 gtccccgcgg ctctgtgtcc cctgctagcc gtaggccgtg tgacccgcag gcaccgggag 61 atccagaagt gaaacgccag gctctctgga ggccaggaga tggtgtgatt tgtccagaga 121 atctttccta agaggaaatc ccagagaagc aggagaaaga gaaagaaatg gctggtgctc 181 agactctgtt gacgttcagg gatgtggcca tagaattctc cctggaggag tggaaatgcc 241 tggacctcgc tcagcagaat ttgtacaggg atgtgatgtt ggagaactac agaaacttgt 301 tctccgttgg tctcactgtc tgtaagccag gcctgatcac ctgcctggag caacgaaaag 361 agccctggaa tgtgaagaga caggaggcag cagacggaca tccagcactg tgctcacctg 421 gggtgctgca aactgtgaaa tggtttttag agttcagatg catcttctca ctagctatgt 481 cttctcattt tacccaagac cttctgccag agcagggcat acaagatgca ttcccaaaaa 541 gaatactgag aggatatgga aattgtggcc ttgataattt atatttaagg aaagactggg 601 aaagtttaga tgagtgtaag ttgcaaaaag attataatgg acttaaccaa tgttcatcaa 661 ctacccatag caaaatcttt caatataata aatatgttaa aatctttgat aacttttcaa 721 atttacatag acgtaatata agtaatactg gagagaaacc tttcaaatgt caagaatgtg 781 gcaaatcctt tcaaatgctc tcattcctaa ctgaacatca gaaaattcac actggaaaaa 841 aaattccaaa aatgtggaga atgtggcaaa acctttatcc agtgctcaca ctttactgaa 901 cctgagaaca ttgacactgg agagaaacct tacaagtgtc aagaatgtaa caacgtcatt 961 aaaacttgct cagtccttac taaaaataga atttatgccg ga //